This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Insulin Resistance, Diabetes or End Stage Renal Disease
and you are
between 18 and 70
years old
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

The purpose of this study is to determine whether Retinol binding protein 4 has a role in insulin resistance development in patients suffering from end stage renal disease on hemodialysis.
Tris trial is registered with FDA with number: NCT00910130. The sponsor of the trial is IRCCS Policlinico S. Matteo and it is looking for 30 volunteers for the current phase.
Official trial title:
Insulin Resistance And End Stage Renal Disease: The Role Of Retinol Binding Protein 4